Initiation of trial marks milestone for Crinetics’ novel nonpeptide drug conjugate platformSAN DIEGO, Dec. 03, 2025 (GLOBE ...
A Calgary man says he’s facing cancer treatment delays because the specialized therapy he needs is not yet being offered at ...
A new 15-year deal between biotech firm Bicycle Therapeutics and the UK Nuclear Decommissioning Authority could see cancer patients benefiting from precision treatments using reprocessed uranium from ...
Radiopharmaceuticals work by delivering radiotherapy directly to cancer cells, destroying tumours while reducing the chances ...
A groundbreaking 15-year partnership between biotech company Bicycle Therapeutics and the UK Nuclear Decommissioning ...
In a new move linking nuclear science and cutting-edge healthcare, the UK is set to produce tens of thousands of doses of ...
Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today ...
Interesting Engineering on MSN
UK firm to tap 440 tons spent nuclear fuel for life-saving cancer treatments
The UK Nuclear Decommissioning Authority and Cambridge-based biotech firm Bicycle Therapeutics have entered into a 15-year ...
Cell therapy oncology drug developers Imugene and Chimeric Therapeutics have won FDA support – albeit in different ways.
DelveInsight's Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, ...
Precision treatments tackling the hardest-to-treat cancers set to be produced from hundreds of tonnes of reprocessed uranium from nuclear reactors ...
Key opportunities in the PET Radiotracers market include expanding cancer and neurological diagnostic applications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results